Erratum: A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients (Blood Advances (2020) 4:21 (5580-5588) DOI: 10.1182/bloodadvances.2020002544)

B. Oran, M. de Lima, G. Garcia-Manero

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients (Blood Advances (2020) 4:21 (5580-5588) DOI: 10.1182/bloodadvances.2020002544)'. Together they form a unique fingerprint.

Medicine & Life Sciences